Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Sign In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Institutions & Repositories
  • Query NERD by:
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Sign In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Onoja AB"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    Kinetics of measles antibody by hemagglutination inhibition assay in children in south-west and north-central Nigeria
    (2013) Onoja AB; Adeniji AJ
    Summary Objectives We investigated the antibody level of children against wild measles virus in view of recurrent measles epidemics, in order to provide information on immunization status for health policies and for the global measles mortality reduction initiative. Methods Two hundred and seventy-three children between the ages of 10 months and 13 years were recruited for this study from three hospital facilities in south-west and north-central Nigeria. Serum samples were collected from February to July 2009, and laboratory examination commenced in August of the same year. Measles hemagglutinin (HA) antigen was prepared by culturing the measles vaccine virus strain (Edmonston-Zagreb) in a vero/hSLAM cell line. Serum samples were treated to get rid of potentiating factors, non-specific inhibitors, and agglutinins before the HA/hemagglutination inhibition (HI) procedure. Results Out of the 175 children vaccinated in Ibadan, 60 (34.3%) had an antibody level not sufficient to protect against measles infection. Likewise, 12 (25.0%) vaccinated children from Ilorin had an antibody level not sufficient to protect against measles infection. There was no significant difference in the level of protection between the children in Ibadan and Ilorin (p>0.05). The geometric mean titer (GMT) was 53.83 for males and 48.64 for females. There was no significant difference between the GMTs of females and males in both locations (p>0.05). Also, no significant difference was observed in the GMTs of children in both locations (p>0.05). Conclusions Of the vaccinated children, 157 (57.5%) developed protective measles virus HI antibody, which is not enough to maintain protective herd immunity. Hence there is a need for catch-up and follow-up vaccination programs, especially in rural areas and places with difficult terrains, in order to reduce measles mortality.
THE NERD SYSTEM

Nigeria Education Repository and Databank (NERD) is the official unified digital platform and a one-stop-shop for the national management, administration, and preservation of education data, records, documents and audio-visual assets as a national reference point for education data consistency - supporting the education sector and library services.

QUICK MENU
  • About NERD
  • Contact and Support
  • Other NERD Services
  • Internal/External Examiner Sign up
  • Student/Lecturer's Sign up
  • Regulatory Agencies
ONGOING ACTION
  • Register Your Institution
  • Training
  • Donate Manuscript
  • Donate Parents' Works
  • Investors
  • Annual Prize and Award
  • Thesis & Dissertation
  • Annual Competition
  • Lecturers' Scholarly Article Prizes
  • Essay Prizes
DIGITAL BANK TOOLS
  • Plagiarism Check
  • NCMVS
  • Publish on NERD
  • Peer Review Publications
  • Futile Hypothesis
  • NERD Receipt
  • InfoGraphics

NERD System Copyright © Federal Ministry of Education.

  • Cookie settings  | 
  • Terms and Conditions  |  
  • End Users Agreement  | 
  • Privacy Policy